Back to Tennessee

HB0767 • 2026

Taxes, Business

AN ACT to amend Tennessee Code Annotated, Title 67, Chapter 4, Part 7, relative to taxation.

Education Taxes
Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Hicks G, Haile
Last action
2026-04-08
Official status
Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/14/2026
Effective date
Not listed

Plain English Breakdown

Checked against official source text during the last sync.

Exemption from Business Tax for Certain Prescription Drugs and Medicines

This bill changes Tennessee's business tax laws to exempt certain prescription drugs and medicines with a monthly cost above $590 from being taxed.

What This Bill Does

  • Changes the classification of some prescription drugs and patent medicines so they are not included in the current tax category.
  • Exempts prescription drugs or medicines with a monthly cost above $590 from business taxes.
  • Also exempts services needed for proper handling, storage, administration, patient education, or monitoring of these exempted drugs and medicines.

Who It Names or Affects

  • Businesses that sell prescription drugs and patent medicines in Tennessee.
  • Wholesalers and retailers selling the specified prescription drugs and medicines.

Terms To Know

Medicare Part D Specialty Tier Cost Threshold
The cost limit set by Medicare for certain expensive medications, above which these medications are exempt from business taxes in Tennessee.
Thirty-Day Equivalent Supply
The amount of a prescription drug needed to last one month.

Limits and Unknowns

  • It is unclear how many businesses will be affected by this change.
  • The bill does not specify what happens after the initial exemption period ends in 2025.

Bill History

  1. 2026-04-08 Tennessee General Assembly

    Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/14/2026

  2. 2026-04-01 Tennessee General Assembly

    Action Def. in s/c Finance, Ways, and Means Subcommittee to the Final Calendar 2

  3. 2026-03-25 Tennessee General Assembly

    Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/1/2026

  4. 2025-04-17 Tennessee General Assembly

    Placed on Senate Finance, Ways, and Means Committee calendar for 4/21/2025

  5. 2025-04-14 Tennessee General Assembly

    Placed on Senate Finance, Ways, and Means Committee calendar for 4/15/2025

  6. 2025-04-14 Tennessee General Assembly

    Rule #83(8) Suspended, to be heard in Senate Finance, Ways & Means Committee on 4/15/2025

  7. 2025-04-09 Tennessee General Assembly

    Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/14/2025

  8. 2025-03-05 Tennessee General Assembly

    Placed behind the budget

  9. 2025-03-04 Tennessee General Assembly

    Refer to Senate Finance, Ways & Means Committee w/ negaitve recommendation

  10. 2025-02-26 Tennessee General Assembly

    Placed on s/c cal Finance, Ways, and Means Subcommittee for 3/5/2025

  11. 2025-02-25 Tennessee General Assembly

    Placed on Senate FW&M Revenue Subcommittee calendar for 3/4/2025

  12. 2025-02-18 Tennessee General Assembly

    Refer to Senate F,W&M Revenue Subcommittee

  13. 2025-02-12 Tennessee General Assembly

    Passed on Second Consideration, refer to Senate Finance, Ways, and Means Committee

  14. 2025-02-10 Tennessee General Assembly

    Assigned to s/c Finance, Ways, and Means Subcommittee

  15. 2025-02-10 Tennessee General Assembly

    Introduced, Passed on First Consideration

  16. 2025-02-06 Tennessee General Assembly

    P2C, ref. to Finance, Ways, and Means Committee

  17. 2025-02-05 Tennessee General Assembly

    Intro., P1C.

  18. 2025-02-05 Tennessee General Assembly

    Filed for introduction

  19. 2025-02-04 Tennessee General Assembly

    Filed for introduction

Official Summary Text

Present law requires b
usinesses, vocations and occupations that are taxable
to be

designate
d into certain
classifications
for business tax rates. E
ach person
must
be classified according to the dominant business activity
. Classification two includes p
rescription drugs and patent medicines
. This bill exempts certain p
rescription drugs and pate
nt medicines
, as described below,

from being included in classification two.

Classification tw
o taxpayers pay
3/20 of 1% of all sales by a retailer an
d
3/80 of 1% of all sales by a wholesaler
.

EXEMPTIONS

Present law provides certain exemptions from bus
iness taxes. This bill exempts

certain
prescription drug
s
or medicine
s with a
cost for a
30
-day equivalent supply that exceeds
the medicare part D specialty tier cost threshold for 2025 plan years, as determined by the federal centers for medicare and med
icaid services
.
For the 2025 plan year, the medicare part D specialty tier cost threshold is set at $590.
This bill exempts from business taxes
prescription drugs and patent medicines
that cost more than this threshold for a 30-day supply. This bill als
o exempts s
ervices necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of
such exempt
drugs
and
medicines
.

Current Bill Text

Read the full stored bill text
SENATE BILL 907
By Haile

HOUSE BILL 767
By Hicks G

HB0767
002784
- 1 -

AN ACT to amend Tennessee Code Annotated, Title 67,
Chapter 4, Part 7, relative to taxation.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
SECTION 1. Tennessee Code Annotated, Section 67-4-708(2)(D), is amended by
deleting the subdivision and substituting instead the following:
(D) Prescription drugs and patent medicines not otherwise exempt under § 67-4-
712(g)(1);
SECTION 2. Tennessee Code Annotated, Section 67-4-712, is amended by adding the
following as a new subsection:
(g) The tax imposed by this part does not apply to any receipts from the sale of
the following:
(1) Any prescription drug or medicine with a cost for a thirty-day
equivalent supply that exceeds the medicare part D specialty tier cost threshold
for 2025 plan years, as determined by the federal centers for medicare and
medicaid services (CMS) pursuant to 42 CFR 423.104(d)(2)(iv)(A); or
(2) Services necessary for proper preparation, storage, handling,
administration, patient education, or post-sale monitoring of drugs or medicines
exempt under subdivision (g)(1).
SECTION 3. This act takes effect July 1, 2025, the public welfare requiring it.